αvβ3 Antagonists Based on a Central Thiophene Scaffold
Authors:
- 6 August 2001
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 11 (15) , 2011-2015
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Identification and in vivo efficacy of small-molecule antagonists of integrin αvβ3 (the vitronectin receptor)Drug Discovery Today, 2000
- Ligands to the integrin receptor αvβ3Expert Opinion on Therapeutic Patents, 2000
- Vitronectin Receptor Antagonists: Purine-Based Peptidomimetics2000
- αvβ3 Integrin antagonists as inhibitors of bone resorptionExpert Opinion on Investigational Drugs, 2000
- RGD Mimetics containing a central hydantoin scaffold: α V β 3 vs α IIb β 3 selectivity requirementsBioorganic & Medicinal Chemistry Letters, 2000
- Inhibition of osteoclastic bone resorption in vivo by echistatin, an "arginyl-glycyl-aspartyl" (RGD)-containing proteinEndocrinology, 1993
- Integrins: Versatility, modulation, and signaling in cell adhesionCell, 1992